SecBot SecBot
6-K ·Filed May 28, 2026

ATS

ATS Corp /ATS
MIXED
Impact 6/10
Horizonweeks Processed5mo ago SEC0001394832-26-000017
Notable filing: 6-K
Actionable Insight ◆ Mixed

ATS is undergoing a significant portfolio transformation, exiting transportation and restructuring operations, which creates near-term earnings noise but targets 50-75bps margin expansion in FY2027. The 18.4% bookings decline and 8.5% backlog contraction signal demand softness, particularly in life sciences, that may pressure revenue visibility. Watch Q1 FY2027 revenue guidance of $700M-$740M and monitor whether margin improvement materializes as restructuring costs phase down.

DirectionMixed
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$30.43
T+0 close · May 28, 2026 · via day close
Latest settled
−35.13%
T+60 · $19.74
Vs SPY
−36.86%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 28 $30.43entry
  2. T+1 · 6mo ago +1.61%α +1.37% · $30.92
  3. T+5 · 6mo ago −5.19%α −5.14% · $28.85
  4. T+20 · 5mo ago −7.95%α −4.81% · $28.01
  5. T+60 · 3mo ago −35.13%α −36.86% · $19.74
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

ATS reported Q4 FY2026 results with adjusted revenues of $744.3M (+3.2% YoY) and adjusted EBITDA of $102.5M (+5.6% YoY), but adjusted EPS declined 12.2% to $0.36. The company is executing a major restructuring of its transportation business, incurring $28.3M in reorganization costs and closing facilities, while guiding for modest FY2027 revenue growth and 50-75bps margin expansion. Order bookings fell 18.4% YoY to $704M and backlog declined 8.5% to $1.958B, signaling demand headwinds.

Key Facts

  • Q4 adjusted revenues $744.3M, +3.2% YoY; organic revenue growth was only 1.5%
  • Q4 adjusted EPS $0.36, -12.2% YoY from $0.41
  • Q4 adjusted EBITDA $102.5M, +5.6% YoY; adjusted EBITDA margin improved 31bps to 13.8%
  • Q4 net loss of $16.2M improved from -$68.9M a year ago, driven by $146.9M prior-year EV customer settlement
  • Order bookings $704M, -18.4% YoY; organic bookings declined 19.3%
  • Order backlog $1,958M, -8.5% YoY; life sciences backlog down 10.2% to $1,077M
  • Transportation revenues collapsed 61.1% YoY to $26.6M; segment being restructured and will cease to be reported separately
  • Restructuring charges of $15.2M in Q4; $28.3M in transportation reorganization costs; $9.8M in services reorganization costs
  • Net debt reduced to $1,151.2M from $1,474.5M; leverage ratio improved to 2.8x from 3.9x
  • Free cash flow of $124.1M in Q4, up from $10.3M a year ago
  • FY2027 guidance: Q1 revenues $700M-$740M; modest full-year revenue growth; adjusted operating margin expected to improve 50-75bps
  • Transportation reorganization expected to remove ~$50M in dilutive revenues in FY2027

Financial Impact

Q4 adjusted revenues $744.3M (+3.2% YoY), adjusted EPS $0.36 (-12.2% YoY), adjusted EBITDA $102.5M (+5.6% YoY). FY2026 full-year adjusted revenues $2,970.1M (+10.8% YoY), adjusted EPS $1.69 (+15.0% YoY).

revenueepsebitdaorder_bookingsorder_backlogdebt

Risk Factors

  • Order bookings declining 18.4% YoY with organic bookings down 19.3% signals weakening demand pipeline
  • Life sciences revenue fell 9.3% YoY and backlog dropped 10.2%, the company's largest end market
  • Transportation restructuring carries execution risk; $28.3M in reorganization costs already booked with more expected
  • Tariff exposure: ~20% of adjusted revenues from Canadian/European operations sold into the U.S. face potential tariff impacts
  • Adjusted EPS declining 12.2% YoY despite revenue growth indicates margin pressure from restructuring costs

Market Snapshot

Exchange
NYSE
Sector
General Industrial Machinery & Equipment, NEC
Analyst Consensus
82% bullish (11 analysts)

Investment Themes

Industrials & Manufacturing

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001394832-26-000017
Document: form6k-fy26q4.htm0001394832-26-000017
Document: 0001394832-26-000017-index-headers.html0001394832-26-000017
Document: 0001394832-26-000017-index.html0001394832-26-000017
Document: 0001394832-26-000017.txt0001394832-26-000017

Track record

13 reports on ATS

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +10.42% at T+60 after the Aug 6, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $16.97 to $17.50 Now $17.96 +5.83% ▲ +3.12% +0.53% vs SPY
  2. Nov 4, 202612d ago 6-K Bearish 6/10 Entry $17.57 to $17.65 Now $17.96 −2.22% ▼ −0.46% −1.37% vs SPY
  3. Oct 30, 202617d ago 6-K Neutral 2/10 Entry $18.97 to $17.74 Now $17.96 −5.32% ▼ −6.48% −6.56% vs SPY
  4. Sep 3, 202610w ago 6-K Neutral 2/10 Entry $19.57 to $19.20 Now $17.96 −8.23% ▼ −1.89% −0.74% vs SPY
  5. Aug 9, 202614w ago Institutional Cluster Bearish 5/10 Entry $19.73 to $19.59 Now $17.96 +8.97% ▲ +0.71% +0.66% vs SPY
  6. Aug 7, 202614w ago 6-K Neutral 2/10 Entry $21.13 to $20.31 Now $17.96 −15.00% ▼ −3.88% −4.28% vs SPY
  7. Aug 6, 202614w ago 6-K Bearish 7/10 Entry $20.53 to $20.13 Now $17.96 +12.52% ▲ +1.95% +3.16% vs SPY
  8. Jul 27, 202616w ago 6-K Neutral 2/10 Entry $26.59 to $27.24 Now $17.96 −32.46% ▲ +2.44% +1.37% vs SPY
  9. Jul 2, 202619w ago 6-K Neutral 2/10 Entry $27.68 to $27.74 Now $17.96 −35.12% ▲ +0.22% −0.71% vs SPY
  10. Jun 11, 202622w ago 6-K Neutral 2/10 Entry $26.88 to $28.32 Now $17.96 −33.18% ▲ +5.36% +4.92% vs SPY
Showing 10 of 13

US Market Status

Market Closed · Opens Wed (10h 53m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 28, 2026